Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 18,132
Avg Vol 7,124
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 53%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

CelLBxHealth plc, a medical diagnostic company, develops cancer diagnostics products in the United Kingdom, Europe, North America, and internationally. The company develops Parsortix PC1 systems, a medical device for the capture and harvest of intact circulating tumour cells (CTCs) from metastatic breast cancer patient blood for subsequent user-validated downstream analysis; and Parsortix PR1 system captures and harvests circulating tumour cells from blood. It also provides Portrait+ CTC Stainin...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 44 14 8334 3434
Address:
Surrey Research Park, Ground Floor 10 Nugent Road, Guildford, United Kingdom
Latest News on ANPCY
No data available.